Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significance greater » significantly greater (Expand Search), significance level (Expand Search), significance set (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
Showing 81 - 100 results of 1,367 for search '(( significant decrease decrease ) OR ( significance greater decrease ))~', query time: 0.41s Refine Results
  1. 81
    Epac activation with 8CPT-AM induced RLC phosphorylation in the perfused hearts.

    Epac activation with 8CPT-AM induced RLC phosphorylation in the perfused hearts. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 82
    Epac activation increased MYPT phosphorylation via PLC/PKC.

    Epac activation increased MYPT phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 83
    Schematic summary of the proposed role of Epac1 in the regulation of myofilament function.

    Schematic summary of the proposed role of Epac1 in the regulation of myofilament function. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 84
    Functional characterization of skinned myocardium prepared from Epac1TG.

    Functional characterization of skinned myocardium prepared from Epac1TG. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 85
    Epac activation increased RLC phosphorylation via PLC/PKC.

    Epac activation increased RLC phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 86
    Phosphorylation status of myofilament proteins prepared from Epac1TG.

    Phosphorylation status of myofilament proteins prepared from Epac1TG. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 87
    Effects of chronic ISO infusion on cardiac function in Epac1TG.

    Effects of chronic ISO infusion on cardiac function in Epac1TG. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 88
    Epac1 expression in the hearts of NTG and Epac1TG.

    Epac1 expression in the hearts of NTG and Epac1TG. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 89
    Effects of pre-medication and warming device on systolic (SAP), diastolic (DAP) and mean (MAP) arterial pressures in dogs following pre-medication, induction and inhalant anesthesia.

    Effects of pre-medication and warming device on systolic (SAP), diastolic (DAP) and mean (MAP) arterial pressures in dogs following pre-medication, induction and inhalant anesthesi... by Jacob P. Rastas (20642173)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 90
    Change in rectal temperature following pre-medication, induction and inhalant anesthesia.

    Change in rectal temperature following pre-medication, induction and inhalant anesthesia. by Jacob P. Rastas (20642173)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 91
    Effects of pre-medication and warming device on heart rate (HR) assessed by pulse oximetry in dogs following pre-medication, induction and inhalant anesthesia.

    Effects of pre-medication and warming device on heart rate (HR) assessed by pulse oximetry in dogs following pre-medication, induction and inhalant anesthesia. by Jacob P. Rastas (20642173)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 92
    S1 File -

    S1 File - by Jacob P. Rastas (20642173)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 93
    Times to tracheal extubation, sternal recumbency and standing (minutes) following inhalant anesthesia and final rectal temperatures (°C) in each premedication-treatment group.

    Times to tracheal extubation, sternal recumbency and standing (minutes) following inhalant anesthesia and final rectal temperatures (°C) in each premedication-treatment group. by Jacob P. Rastas (20642173)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 94
    AVAcore placement.

    AVAcore placement. by Jacob P. Rastas (20642173)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 95
    Change in Watt’s Connectedness Scale, Subscales by Treatment Group.

    Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 96
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 97
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 98
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 99
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 100
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: